Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.
Rienstra M, Sun JX, Lubitz SA, Frankel DS, Vasan RS, Levy D, Magnani JW, Sullivan LM, Meigs JB, Ellinor PT, Benjamin EJ.
Am Heart J. 2012 Jan;163(1):119-124.e1. Epub 2011 Nov 17.
Related citations
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Verheugt FW, Jamal W, Misselwitz F, Rushton-Smith S, Turpie AG.
Am Heart J. 2012 Jan;163(1):13-19.e1. Epub 2011 Nov 20.
A randomized study of the effects of exercise training on patients with atrial fibrillation.
Osbak PS, Mourier M, Kjaer A, Henriksen JH, Kofoed KF, Jensen GB.
Am Heart J. 2011 Dec;162(6):1080-7.
Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score.
Roe MT, Chen AY, Thomas L, Wang TY, Alexander KP, Hammill BG, Gibler WB, Ohman EM, Peterson ED.
Am Heart J. 2011 Nov;162(5):875-883.e1. Epub 2011 Oct 5.
Letter to the editor regarding "Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction".
Smith SW, Dodd KW.
Am Heart J. 2011 Oct;162(4):e23. Epub 2011 Aug 10. No abstract available.
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.
Piccini JP, Fraulo ES, Ansell JE, Fonarow GC, Gersh BJ, Go AS, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Kong MH, Lopes RD, Mills RM, Peterson ED.
Am Heart J. 2011 Oct;162(4):606-612.e1.
Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke.
Lewis WR, Fonarow GC, Grau-Sepulveda MV, Smith EE, Bhatt DL, Hernandez AF, Olson D, Peterson ED, Schwamm LH.
Am Heart J. 2011 Oct;162(4):692-699.e2. Epub 2011 Sep 15.
The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.
Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP.
Am Heart J. 2011 Sep;162(3):555-61. Epub 2011 Aug 9.
Clinical significance of late high-degree atrioventricular block in patients with left ventricular dysfunction after an acute myocardial infarction--a Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) substudy.
Gang UJ, Jøns C, Jørgensen RM, Abildstrøm SZ, Messier MD, Haarbo J, Huikuri HV, Thomsen PE.
Am Heart J. 2011 Sep;162(3):542-7. Epub 2011 Aug 11.
Vitamin D status is not related to development of atrial fibrillation in the community.
Rienstra M, Cheng S, Larson MG, McCabe EL, Booth SL, Jacques PF, Lubitz SA, Yin X, Levy D, Magnani JW, Ellinor PT, Benjamin EJ, Wang TJ.
Am Heart J. 2011 Sep;162(3):538-41. Epub 2011 Aug 11.
Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.
Stefano B, Pietro RR, Maurizio G, Maurizio L, Renato M, Maurizio L, Pietro R, Alessandro P, Gianluca B, Monica M, Sergio C, Massimo S.
Am Heart J. 2011 Aug;162(2):390-7. Epub 2011 Jul 7.
Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, Franzosi MG, Lucci D, Staszewsky L, Fabbri G, Quintarelli S, Bianconi L, Latini R.
Am Heart J. 2011 Aug;162(2):382-9. Epub 2011 Jul 7.
Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation.
Winkle RA, Mead RH, Engel G, Patrawala RA.
Am Heart J. 2011 Jul;162(1):193-200.
Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
Mitchell JE, Tam SW, Trivedi K, Taylor AL, O'Neal W, Cohn JN, Worcel M.
Am Heart J. 2011 Jul;162(1):154-9.
The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design.
Mozaffarian D, Marchioli R, Gardner T, Ferrazzi P, O'Gara P, Latini R, Libby P, Lombardi F, Macchia A, Page R, Santini M, Tavazzi L, Tognoni G.
Am Heart J. 2011 Jul;162(1):56-63.e3. Epub 2011 Jun 12.
Differential impact of race and risk factors on incidence of atrial fibrillation.
Gbadebo TD, Okafor H, Darbar D.
Am Heart J. 2011 Jul;162(1):31-7. Review.
High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Schwartz GG, Chaitman BR, Goldberger JJ, Messig M.
Am Heart J. 2011 May;161(5):993-9.
The epidemiology of atrial fibrillation in adults depends on locale of diagnosis.
Sandhu RK, Bakal JA, Ezekowitz JA, McAlister FA.
Am Heart J. 2011 May;161(5):986-992.e1.
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.
Mehta RH, Starr AZ, Lopes RD, Piccini JP, Patel MR, Pieper KS, Armstrong PW, Granger CB.
Am Heart J. 2011 Apr;161(4):782-9. Epub 2011 Mar 5.
Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction.
Kontos MC, Aziz HA, Chau VQ, Roberts CS, Ornato JP, Vetrovec GW.
Am Heart J. 2011 Apr;161(4):698-704.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on